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CD8 Lineage Commitment
in the Absence of CD8
Ananda W. Goldrath,* Kristin A. Hogquist,² CD8b tail lacks a motif for interaction with Lck or any
other known signaling molecules. Despite this and theand Michael J. Bevan*
rather small effect of CD8b on the binding affinity for*Department of Immunology and Howard Hughes
class I, eliminating CD8b expression dramatically influ-Medical Institute
ences CD8 lineage development. Thymocytes fromUniversity of Washington
CD8b-deficient mice produce very few CD8 single posi-Seattle, Washington 98195
tive cells (Crooks and Littman, 1994; Fung-Leung et al.,²Department of Laboratory Medicine and Pathology
1994), and thymocytes overexpressing a tailless CD8bUniversity of Minnesota Medical School
molecule are also poorly selected into this lineage (ItanoMinneapolis, Minnesota 55455
et al., 1994). These findings raise the possibility that
CD8b may contribute in some unknown but critical way
to the selection of class I±restricted T cells.Summary
In CD8a-deficient (CD88) mice, MHC class I±restricted
cytotoxic T lymphocytes (CTL) appear to be completelyThe absence of cytotoxic T lymphocyte activity and
absent (Fung-Leung et al., 1991a; Fung-Leung et al.,the failure of MHC class I±restricted T cell receptor
1991b; Fung-Leung et al. 1993a; Bachmann et al., 1995).(TCR) transgenic thymocytes to mature in CD8a-defi-
No significant CD42TCRhi T cell population is observedcient mice suggest that CD8 may be essential for CD8
in the CD88 mice in excess of the numbers normallylineage commitment. We report that variants of the
observed in CD8 wild-type mice. More remarkable thanantigenic peptide that delete TCR transgenic thymo-
this phenotypic characteristic is the paucity of cytolyticcytes from CD8 wild-type but not CD8a-deficient mice
function after in vivo introduction of potent immunogenscan restore positive selection of CD8 lineage cells in
such as lymphocytic choriomeningitis virus (Fung-the absence of CD8. The positively selected cells
Leung et al., 1991b), vesicular stomatitis virus (Bach-down-regulate CD4, up-regulate TCR, respond to the
mann et al., 1995), or immunization with allogeneic cellsantigenic peptide, and express CD8b mRNA. Interest-
(Fung-Leung et al., 1991a). A number of lines of miceingly, there was no enhanced selection of CD41 T cells,
transgenic for MHC class I±restricted TCRs also fail toimplying that the TCR±MHC interaction, even in the
give rise to CD8 lineage cells when crossed onto theabsence of CD8, provided instructive signaling for
CD88 background (Fung-Leung et al., 1993). In summary,commitment to the CD8 lineage. Our results are dis-
detection of CD8 ªwannabesº in CD8a-deficient mice iscussed in terms of recent models of T cell lineage
difficult. This is in contrast with CD48 mice, which readily
commitment.
generate MHC class II±restricted responses to foreign
antigens mediated by CD42CD82TCRhi CD4 ªwan-
Introduction nabesº (Locksley et al., 1993; Rahemtulla et al., 1994).
Further indications of the different requirements for
The CD8 molecule on the surface of T cells serves as a commitment to the CD4 versus CD8 lineage come from
coreceptor for T cell receptor (TCR) recognition of major studies using anti-TCR antibodies to drive positive se-
histocompatibility (MHC) class I±associated peptides. lection. In MHC-deficient (class II8, b2m8) mice, mature
CD8 may be involved in positive selection either by sta- CD4 single positive cells, but not CD8 single positive
bilizing TCR±MHC interactions or by enhancing the acti- T cells, can be selected by intraperitoneal injection of
vation of essential intracellular signaling components anti-TCR antibodies (Muller and Kyewski, 1993, 1995).
(Zamoyska, 1994). CD8 exists on the cell surface as a Similarly, in fetal thymic organ culture (FTOC) of MHC-
disulfide-linked transmembrane heterodimer of a and b deficient lobes, deaggregated anti-TCR antibodies pref-
chains (Parnes, 1989). In the absence of CD8b expres- erentially promote the selection of CD4 lineage cells
sion, CD8a homodimers reach the surface, whereas in (Takahama et al., 1994). Other studies analyzing the co-
the absence of CD8a, CD8b is retained and destroyed receptor reexpression patterns of immature thymocyte
within the cell. The extracellular immunoglobulin do- subsets have suggested that CD8 lineage commitment
mains of CD8 homodimers and heterodimers bind the is dependent on TCR interactions with MHC class I and
membrane-proximal region of MHC class I molecules therefore may involve a necessary CD8-dependent sig-
(Potter et al., 1987; Salter et al., 1990; Sun et al., 1995). nal. In contrast, CD4 lineage±committed cells are appar-
Soluble CD8a homodimers bind MHC class I with ap- ent in the thymus of MHC class II±deficient mice using
proximately 3-fold lower affinity than do soluble CD8ab this assay (Suzuki et al., 1995).
heterodimers (Garcia et al., 1996). Studies with both We wanted to address whether expression of CD8 on
whole cells and purified components have shown that the thymocyte surface is essential for positive selection
CD8 stabilizes the interaction between the TCR and of the CD81 CTL lineage. To do this, we used a system
MHC-associated peptide ligands (Lueshcher et al., in which we can control the affinity of the interaction
1995; Garcia et al., 1996; Renard et al., 1996). between a transgenic TCR and the MHC-associated
The CD8a cytoplasmic tail associates with the Src peptide ligands that drive selection (Alam et al., 1996).
family tyrosine kinase, Lck, a molecule critically involved OT-1 TCR transgenic mice express a TCR that recog-
in TCR-mediated signaling (Veillette et al., 1988; Rudd nizes the octameric peptide OVA257±263 in the context
of H-2Kb, and thymocytes expressing this receptor areet al., 1989; Miceli and Parnes, 1993). In contrast, the
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Figure 1. In Vitro Deletion and CD69 Expres-
sion of CD88OT-1 and CD8WTb2m8OT-1 Thy-
mocytes by OVAp Variants
Thymocytes from CD88OT-1 and
CD8WTb2m8OT-1 were cultured with irradi-
ated EL4 cells and titrations of OVAp (crossed
squares), T1 (circles), E1 (open squares), or
polySER (triangles) peptides for 18 hr. Cells
were harvested and analyzed for expression
of CD4, CD8, and CD69 by flow cytometry.
The percentage deletion of viable thymocytes
(a and c) and CD69 mean fluorescence inten-
sity (MFI) for total thymocytes (b and d) are
shown.
positively selected into CD8 single positive cells by rec- (Figures 1b and 1d). Thus, CD88OT-1 thymocytes are
approximately 100-fold less sensitive to deletion andognition of natural peptide ligands presented by H-2Kb
(Hogquist et al., 1994). Variants of the antigenic oval- CD69 induction by OVAp than their counterpart CD8WT
thymocytes.bumin peptide (OVAp) that act as antagonists or weak
agonists for CTL bearing the OT-1 TCR have been de- E1 (EIINFEKL), an OVAp variant previously shown to
be a weak agonist of the OT-1 TCR (Jamesonet al., 1993;fined (Jameson et al., 1993; Barnden et al., 1994; Hog-
quist et al., 1994; Jameson et al., 1994). We have shown Hogquist et al., 1994; Jameson et al., 1994), induced
deletionand CD69 expression in CD8WTOT-1 thymocytespreviously that such variants can restore positive selec-
tion when added to FTOC of OT-1 transgenic, b2m8 approximately 1000-fold less efficiently than did OVAp
(Figures 1a and 1b) but had no effect on CD88OT-1 thy-mice (Hogquist et al., 1994). In the absence of the CD8
coreceptor, OT-1 thymocytes are not positively selected mocytesat any concentration tested (Figures1c and 1d).
The T1 (TIINFEKL) variant is a strong agonist (Barnden etby normal levels of H-2Kb. We asked whether selection
could be restored, in this case, by the addition to FTOC al., 1994) and induced deletion and CD69 expression in
CD8WTOT-1 thymocytes only about 10-fold less effi-of OVAp variant peptides that serve as strong agonists
for the OT-1 transgenic T cells. ciently than OVAp (Figures 1a and 1b). Surprisingly,
given its similarity to OVAp in the dose response curve,Our results show that positive selection of thymocytes
bearing an MHC class I±restricted TCR can be restored T1 also had no effect on CD88OT-1 thymocytes at any
concentration tested (Figures 1c and 1d). A control pep-in the absence of CD8 expression by increasing the
affinity of the TCR±MHC ligand interaction. Curiously, tide that binds to H-2Kb, polySER (SSYSYSSL) (Hogquist
et al., 1994), did not induce deletion of either CD8WTOT-1this TCR±MHC class I interaction, even in the absence of
CD8, appears to direct commitment to the CD8 lineage. or CD88OT-1 thymocytes (Figure 1). Several other OVAp
variants that have been described as strong agonists
for the OT-1 TCR, A2, H7, and R7 (Barnden et al., 1994)Results
were found to delete both CD88OT-1 and CD8WTOT-1
thymocytes. Furthermore, nontransgenic C57BL/6 thy-Identification of Peptide Variants for Selection
of CD88OT-1 Thymocytes mocytes were not deleted by any of the peptides tested
(data not shown).We reasoned that peptide±MHC complexes that had
higher affinity for the TCR than those previously used The E1 and T1 variants were also tested for their ability
to target killing by a CD8WTOT-1 CTL line in a short-to mediate positive selection of CD8WTOT-1 thymocytes,
but that did not delete CD88OT-1 thymocytes, would term 51Cr-release assay (Table 1). CD8WTOT-1 CTL killed
targets coated with OVAp and T1. However, when aprovide candidate ligands for positive selection of
CD88OT-1 thymocytes. Variants of OVAp (SIINFEKL) that saturating amount of an anti-CD8 monoclonal antibody
was added to the assay to block CD8±MHC interactions,have been described as agonists for T cells bearing the
OT-1 TCR, either in CTL targeting or thymocyte deletion lysis of OVAp targets required approximately 100-fold
more peptide to achieve the level of killing observed inassays (Jameson et al., 1993; Barnden et al., 1994; Hog-
quist et al., 1994; Jameson et al., 1994), were tested for wells in the absence of blocking antibody, whereas T1
targets were not lysed at any peptide concentration.their ability to induce deletion and CD69 up-regulation
of CD88OT-1 thymocytes. In an in vitro deletion assay, Similarly, E1 targeted for low levels of lysis, which was
completely blocked by the addition of an anti-CD8 anti-OVAp deleted CD8WTOT-1 thymocytes approximately
100-fold more effectively on a dose response curve than body (data not shown).
We find that for immature thymocyte deletion, thymo-it did CD88OT-1 thymocytes (Figures 1 a and 1c). The
dose response curve for deletion correlates well with cyte CD69 up-regulation (Figure 1), and CTL-mediated
lysis (Table 1), the loss of the CD8 coreceptor can bethe induction of CD69 expression on the thymocytes
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Table 2. Total Cell Yield and Recovery of CD42Va2hi Cells fromTable 1. CD8 Dependence of CD8WTOT-1 CTL±Mediated
Cytolysisa FTOC
% Specific Lysis in the Thymus Donor No Peptide E1a T1 OVAp
Presence of MAb
CD88OT-1 5.5 (2.5)b 4.8 (2.1) 6.6 (2.0) 1.7 (0.8)
0.7c 3.3 5.4 1.1Peptide No MAb aCD8 MAb
CD8WTOT-1 4.2 (0.8) 1.5 (0.4) 2 (0.1) 1 (0.1)
OVAp 1028 M 51 35
OVAp 10210 M 38 27 a All peptides were present at 50 mM.
b Cell yield per lobe 3 1025 (standard deviation).T1 1028 M 33 5
T1 10210 M 5 5 c CD42Va2hi cell yield per lobe 3 1025.
a CTL line from OT-1 TCR transgenic mice used at 1:1 effector:target
ratio with 51Cr-labeled EL4 target cells precoated with the indicated
peptides. The assay was performed in the presence or absence
peptides was decreased 2- to 4-fold compared to con-of saturating amounts of blocking anti-CD8 monoclonal antibody
trol cultures without added peptide (Table 2). Thus, pep-(MAb).
tides that induce deletion of adult CD8WTOT-1 thymo-
cytes in the suspension culture assay also induce
deletion in FTOC.
compensated for by an approximately 100-fold increase
in OVAp concentration. These findings are consistent E1 and T1 Peptides Positively Select
with data that show that presentation by cells bearing CD88OT-1 Thymocytes in FTOC
an a3-mutant H-2Kb molecule that interferes with CD8± Culture of CD88OT-1 thymic lobes in the absence of
MHC binding requires 100-fold more OVAp to stimulate added peptide resulted in the generation of a cell popu-
OVA-specific CTL clones than cells expressing wild- lation that was largely CD41 and that expressed low to
type H-2Kb (Knall et al., 1994). intermediate levels of Va2 (Figures 3a and 3b). These
cells appeared to be nonselected and probably corre-
E1 and T1 Peptides Delete CD8WTOT-1 spond to the CD41CD81 subset in wild-type mice. Only
Thymocytes in FTOC 13% of the recovered cells had up-regulated Va2 ex-
FTOC of CD8WTOT-1 thymic lobes allows the efficient pression and down-regulated CD4 (Figure 3b).
positive selection of CD8 single positive cells without Inclusion of OVAp, E1, or T1 peptides in the FTOC
the addition of peptide (Figure 2). When the agonist led to a dramatic change in the recovered populations
peptides E1, T1, or OVAp were added to cultures at 50 (Figure 3). The recovery of CD41 thymocytes was de-
mM, the cells recovered from FTOC were predominantly creased, with a corresponding increase in the recovery
CD42CD82 and Va2hi, as shown previously for OVAp of Va2hi cells that were CD42. Another peptide variant,
(Figure 2) (Hogquist et al., 1994; Hogquist et al., 1995). VOVA, which has been shown to be an even weaker
Also, cell recovery from cultures treated with agonist agonist for the OT-1 TCR than E1 (Hogquist et al., 1994),
induced deletion and CD69 expression of CD8WTOT-1
thymocytes only at very high concentrations and not at
any concentration for CD88OT-1 thymocytes. VOVA had
no effect on CD88OT-1 thymocytes in FTOC (data not
shown). Although the superficial outcomes with OVAp,
E1, and T1 peptides were similar, further analysis showed
that while OVAp cultures represented the production
of unresponsive CD42CD82 cells, E1 and T1 cultures
represented positive selection of functional CD8 lineage
cells. Selection of thymocytes with wild-type coreceptor
expression was studied by observing the transition of
CD41CD81TCRlo cells to either CD81TCRhi cells (positive
selection) or to CD42CD82TCRhi cells (deletion). In the
absence of CD8 expression, it becomes more difficult to
distinguish the outcome of FTOC by surface phenotype
alone. Even though we had previously shown that E1
and T1 do not cause deletion of CD88OT-1 thymocytes
in suspension culture deletion assays (Figure 1), it was
conceivable that they could delete in FTOC. Therefore,
we further characterized the CD42Va2hi cells generated
in FTOC by these peptides.
First, the absolute cell recoveries from FTOC differed
dramatically depending on the peptide added. Notably,
Figure 2. Agonist Peptides E1, T1, and OVAp Cause Deletion of
similar numbers of cells were recovered from culturesCD8WTOT-1 Thymocytes in FTOC
to which E1 or T1 was added and cultures to which no
FTOC was performed with CD8WTOT-1 transgenic thymic lobes in
peptide was added, suggesting that E1 and T1 were notthe presence of media or 50 mM E1, T1, or OVA peptides. Thymo-
mediating deletion (Table 2). Cultures to which OVApcytes from cultured lobes were harvested after 7 days, counted,
and analyzed for expression of CD4 and CD8 by flow cytometry. was added, on the other hand, yielded approximately
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Figure 4. Phenotypic Analysis of Peptide Selected CD88OT-1 Cells
Recovered from FTOC
Thymocytes from CD88OT-1 FTOC were stained for CD4 and CD8
with either Va2 (total thymocytes) (a), HSA (CD42 gated thymocytes)
(b), or H-2Kb (CD42 gated thymocytes) (c). Histograms of Va2, HSA,
and H-2Kb expression are shown for cells recovered from the follow-
Figure 3. Agonist Peptides E1, T1, and OVAp Select CD42Va2hi Cells ing FTOC conditions: no peptide (thin solid line), 50 mM OVAp (thick
in CD88OT-1 FTOC gray line), T1 (thin gray line), or E1 (thick solid line).
CD88OT-1 transgenic thymic lobes were cultured in the presence
of media or 50 mM E1, T1, or OVA peptides. Thymocytes from cul-
tured lobes were harvested on day 7, counted, and analyzed for T1 peptides, as expected for cells that have undergone
expression of CD4, CD8, and Va2 by flow cytometry. (a) CD8 versus positive selection (Figures 3b and 4a). The OVAp-
CD4 expression for each culture condition. (b) CD4 versus Va2 ex- selected cells showed only a modest up-regulation of
pression for each culture condition.
Va2 expression (Figures 3b and 4a). Although the CD42
cells generated in FTOC to which OVAp, E1, or T1 pep-
tide had been added were all HSAlo (Figure 4b) and3.5-fold fewer cells than cultures to which E1, T1, or
no peptide was added. This is similar to the deletion had up-regulated H-2Kb, the OVAp-selected CD42 cells
differed from the E1- and T1-selected cells in that theyobserved in FTOC of CD8WTOT-1 thymocytes cultured
with the agonist peptides E1, T1, and OVAp, which expressed slightly higher levels of H-2Kb (Figure 4c). In
contrast to the cells recovered from FTOC receivingshowed a 2- to 4-fold decrease in cell recovery com-
pared to FTOC in which cells were positively selected peptide, cells from the control FTOC receiving no pep-
tide were Va2lo, and the few CD42 cells present in thesein the absence of exogenous peptide (Table 2). In addi-
tion, in terms of the yield of cells with a selected pheno- cultures did not significantly down-regulate HSA or up-
regulate H-2Kb expression. Thus, these cells do not rep-type (i.e., CD42Va2hi), both E1 and T1 promoted a 3- to
7-fold higher yield above that of the control, no-peptide resent mature cells that have escaped the requirement
for CD8.cultures, whereas OVAp cultures did not (Table 2). The
variant peptide, VOVA, which appeared to have no phe-
notypic effect in FTOC of CD88OT-1 thymic lobes, E1- and T1-Selected Thymocytes
Respond to OVApyielded numbers of cells similar to those of cultures that
received no peptide (data not shown). CD88OT-1 thymocytes recovered from FTOC were
tested for their ability to respond to cognate antigen inTo characterize further the maturation state of the
peptide-selected cells, TCR, HSA, and H-2Kb expression a proliferation assay. Cells recovered from FTOC were
cultured with irradiated antigen-presenting cells in thelevels were analyzed (Figure 4). Following FTOC, Va2
was markedly up-regulated in cultures receiving E1 and presence or absence of OVAp. Minimal proliferation in
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sorted into CD42Va2hi (selected) and CD41Va2lo (nonse-
lected) populations for RT-PCR analysis. Levels of
CD8b, CD4, and HPRT mRNA were compared to the
CD42Va2hi sorted cells obtained from OVAp FTOC (Fig-
ure 7). CD8b message was detected in the CD42Va2hi
population derived from E1- and T1-selected cultures.
CD8b message was also detected in the CD41Va2lo pop-
ulations derived from E1- and T1-selected cultures, as
would be expected of double positive thymocytes. How-
ever, no detectable CD8b message was observed in the
CD42Va2hi population recovered from FTOC to which
OVAp was added. CD4 message was detected only in
the CD41Va2lo populations. Because there was no de-
tectable CD4 mRNA in the CD42Va2hi population, theFigure 5. CD88OT-1 Thymocytes Selected by OVAp Variants Prolif-
erate in Response to Antigen CD8b message observed is unlikely to be contributed
FTOC was performed with CD88OT-1 transgenic fetuses as de- by a low level of contaminating CD41Va2lo cells. Impor-
scribed in Figure 3. Thymic lobes were cultured for 7 days in the tantly, cells undergoing deletion induced by OVAp in
presence of media or 50 mM E1, T1, or OVA peptides. At the end FTOC, of which the majority are CD42Va2hi, did not ex-
of FTOC, cells were harvested and added to cultures at one quarter-
press any detectable CD4 or CD8b mRNA; they ap-lobe equivalent per well with irradiated TAP8 splenocytes as antigen-
peared to be true CD42CD82 cells. This indicates thatpresenting cells with or without 100 nM OVAp. Cultures were pulsed
CD42Va2hi cells that were selected by E1 and T1 in FTOCfor 8 hr with [3H]thymidine after 36 hr of culture. Data are shown as
the mean and standard deviation and are representative of three were of the CD8 lineage and confirms that this selective
experiments. process was clearly distinct from thymocyte deletion
induced in the presence of OVAp.
response to stimulation with OVAp was observed for
Discussioncells from FTOC to which no peptide or OVAp had been
added (Figure 5). In contrast, a vigorous response to
To investigate further the role of the CD8 molecule inOVAp was observed for E1- and T1-selected cells. This
thymocyte lineage commitment, we have used variantsresult demonstrated that functional cells were selected
of the cognate peptide to manipulate the affinity of thein FTOC by E1 and T1, whereas OVAp induced deletion
selecting ligand for the OT-1 TCR in the absence of CD8and functional tolerance of CD88OT-1 thymocytes.
expression. CD88OT-1 thymocytes are deleted in FTOCTo confirm that the observed antigen-specific prolifer-
and in suspension cultures by the cognate antigen,ation was due to the selected CD42Va2hi cells and not
OVAp, although less efficiently than are OT-1 thymo-to proliferation of CD41 cells expressing the OT-1 TCR,
cytes expressing CD8. However, even in the absenceidentical proliferation assays were pulsed with bromo-
of CD8, weaker agonists can provide the necessary sig-deoxyuridine (BrdU), and CD4 and Va2 expression was
nal for the positive selection of mature cells that haveanalyzed to allow phenotypic analysis of the proliferat-
up-regulated TCR and H-2Kb expression, have down-ing cells. As expected, BrdU incorporation in response
regulated CD4 and HSA (Figures 3 and 4), respond toto antigen stimulation was observed only in cells from
antigen (Figures 5 and 6), and express CD8b mRNAE1- and T1-selected FTOC (Figure 6a). The proliferating
(Figure 7). This we interpret as illustrating that an in-BrdU1 cells from E1-selected FTOC werenearly all CD42
crease in the affinity of the TCR for the positively select-and Va2hi (Figure 6b). Similar results were obtained from
ing ligand can overcome the need for CD8 coreceptorantigen-specific proliferation of T1-selected cells (data
involvement in this maturation step. It is unlikely that thenot shown). Therefore, the CD42Va2hi cells that were
cells described here correspond to the CD42CD82TCRhiselected by E1 and T1 in FTOC were the cells that prolif-
cells selected in TCRab transgenic mice that appear toerated in response to OVAp.
be of the gd T cell lineage (Bruno et al., 1996). The cells
positively selected by agonists in FTOC from CD88OT-1
thymic lobes proliferate to nominal antigen and expressE1- and T1-Selected Thymocytes
Express CD8b mRNA CD8b mRNA.
In this report we have shown that by providing strongAlthough the CD42Va2hi thymocytes selected by E1 and
T1 inFTOC from CD88OT-1 mice cannot express surface agonist ligands for the TCR, we can restore positive
selection into the CD8 lineage in the absence of the CD8CD8 molecules, we were interested in ascertaining
whether they expressed CD8b mRNA as a marker for molecule. This finding suggests that there may be no
essential requirement for CD8 lineage commitment thattheir commitment to the CD8 lineage. By reverse tran-
scription polymerase chain reaction (RT-PCR), both can be provided only by theCD8 molecule. This possibil-
ity then raises the question as to why CD88 mice them-CD8b and CD4 messages were detected in total adult
CD88 and CD88OT-1 thymocytes as well as in CD88OT-1 selves select undetectable numbers of CD8 lineage
cells, particularly in comparison to CD48 mice, whichcells recovered from FTOC cultured in the absence of
added peptide, showing that it is possible to detect develop easily detectable CD4 lineage cells. To explain
this puzzle, we present the following model (dia-CD8b expression in CD8a-deficient thymocytes (data
not shown). Cells harvested from E1 and T1 FTOC were grammed in Figure 8). In this scheme, TCR affinity for
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Figure 6. E1 and T1 Selected CD88OT-1 Thy-
mocytes Responding to OVAp Are Va2hiCD42
FTOC and proliferation assays were per-
formed as described in Figure 5, except that
after 24 hr in culture, wells were pulsed with
BrdU. Cells were then harvested and surface
stained for expression of CD4 and Va2 prior
to fixation, permeabilization, and intracellular
staining for BrdU. BrdU staining is shown for
cells cultured with OVAp (100 nM) following
selection in FTOC with no peptides or 50 mM
E1, T1, or OVA peptides (a). BrdU versus CD4
expression and BrdU versus Va2 expression
are shown for thymocytes derived from the
E1-selected FTOC (b). BrdU was incorpo-
rated into less than 0.6% of the cells cultured
with media alone for all FTOC conditions.
the selecting MHC ligand and the degree of coreceptor specific, involving many low-affinity interactions with a
diversity of MHC class II ligands on the stromal cell.involvement in the signaling event play distinguishable
roles in the process of thymocyte selection. We propose There is no firm evidence for this contention that CD4
cells are positively selected at lower TCR±MHC affinitiesthat under normal conditions in which mice express a
diverse TCR repertoire as well as both coreceptors, the than are cells of the CD8 lineage. However, in addition
to explaining observations in the coreceptor-deficientselection of CD4 and CD8 lineages occurs at different
windows of TCR±MHC affinity. According to this model, mice, this hypothesis may provide an explanation for
why mice engineered to express a single covalent MHCCD8 lineage cells are normally positively selected at
higher TCR±MHC affinities for the thymic ligand than class II±peptide complex (Ignatowicz et al., 1996) or
mice expressing a single, MHC class II±associated pep-are CD4 lineage cells. Thus, the ability of thymic ligands
to positively select class I±restricted cells may depend tide due to deletion of H2-M appear to select a broad
CD4 TCR repertoire (Fung-Leung et al., 1996; Martin etprecisely on the peptide presented, and for this reason
the density of the appropriate ligand on the stromal al., 1996; Miyazaki et al., 1996). Similar experiments have
not been reported for mice expressing a single selectingcell may be low. In contrast, positive selection of CD4
lineage cells on MHC class II ligands may be less peptide peptide bound to MHC class I.
Figure 7. E1 and T1 Selected CD88OT-1 Thy-
mocytes Express CD8b mRNA
FTOC was performed with CD88OT-1 trans-
genic fetuses as described in Figure 3. Thy-
mocytes were harvested and stained for ex-
pression of CD4, CD8, and Va2. Thymocytes
from E1 and T1 cultures were sorted for
CD41Va2lo and CD42Va2hi populations. Thy-
mocytes from lobes cultured with OVAp were
sorted for CD42Va2hi populations. Following
sorting, each population contained less than
0.3% contamination with the other sorted
population. Total RNAwas isolated and cDNA
was synthesized. HPRT normalized template
was used for PCR amplification of CD4 and
CD8b mRNA titrated in 3-fold serial dilutions.
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We have shown here that it is possible to compensate
for the lack of CD8 expression by increasing the affinity
of the TCR for the positively selecting ligand. Similarly,
although it has not been demonstrated, it is assumed
that the abundant CD4 ªwannabesº that appear in the
CD48 mice were positively selected at higher TCR±MHC
affinity. The critical difference, for our argument, is that
there are far fewer TCRs generated with sufficiently high
affinity for MHC class I than for MHC class II to com-
pensate for the loss of CD8 expression, explaining the
dearth of CD8 ªwannabesº in CD88 mice despite the
abundance of CD4 ªwannabesº in the CD48 mice (Fig- Figure 8. A Model of CD4/CD8 Lineage Commitment in Which the
ure 8). Coreceptor Involvement and TCR±MHC Affinity Contribute Sepa-
We can also use the scheme in Figure 8 to discuss rately to Lineage Choice
other recent work and additional implications that come The number of cells with randomly generated TCRs at each TCR±
MHC affinity explains the observation that CD4 ªwannabesº arefrom the present report. Two recent reports have pro-
present in CD48 mice, but no CD8 ªwannabesº are observed in CD88vided strong support for a quantitative, instructive
mice. We propose that the window for positive selection of CD8model for the CD4/CD8 lineage decision (Itano et al.,
lineage cells is set at a higher TCR±MHC affinity than for CD4 lineage1996; Matechak et al., 1996). Both show that the commit-
cells. Very few naturally generated TCRs are generated that will
ment to the CD4 or CD8 lineage can be switched by react with adequate affinity with MHC to compensate for the loss
altering the coreceptor involvement. According to this of CD8; however, many more cells with TCRs are generated that
model, signals from theTCR of immature double positive will interact with sufficient affinity to mediate selection into the CD4
lineage when CD4 is absent. This model also shows that no alterationthymocytes that can be classified as of low intensity,
in the strength of TCR±MHC interaction will redirect lineage choiceor low Lck involvement, favor commitment to the CD8
from CD8 to CD4 or vice versa. Instead, increasing or decreasinglineage. High-intensity signaling, or strong Lck involve-
TCR±MHC affinity allows only the transit from neglect, through se-ment, would favor commitment to the CD4 lineage. One
lection of a single lineage, to deletion (arrows 1 and 2; see Dis-
study showed that the involvement of the CD4 cyto- cussion). Alternatively, the alteration of coreceptor contribution by
plasmic tailÐwhich associates with Lck more efficiently signaling canredirect lineagechoice, as is proposed by thequantita-
than does the CD8 tail (Veillette et al., 1988, Wiest et tive, instructive model (arrows 3 and 4; see Discussion).
al., 1993; Ravichandran and Burakoff, 1994)Ðfavored
CD4 over CD8 lineage commitment during thymocyte
development (Itano et al., 1996). Thus, the F5 (H-2Db- the CD4 lineage by altering the ligand affinity or density.
restricted) TCR transgenic thymocytes, which normally This may not be surprising with OT-1 thymocytes that
differentiate into the CD8 lineage in thepresence of wild- express CD4 and CD8, since commitment to the CD4
type CD8, commit to the CD4 lineage in the presence lineage would result in down-regulation of CD8 and con-
of a transgenic hybrid coreceptor in which the CD8a
comitant loss of signaling from the class I ligand.
cytoplasmic domain is replaced by the CD4 cytoplasmic
However, in the case of OT-1 mice bred to the CD88
domain (Figure 8, arrow 3). The OT-1 transgenic thymo-
background, it is not obvious why we cannot push cells
cytes behave similarly when expressing this hybrid core-
into the CD4 lineage by changing the MHC ligand forceptor (K. A. H., unpublished). The other report showed
positive selection. The three ligands we have used here,that TCR interactions with MHC class II by AND (H-2Ek±
E1, T1, and OVAp, vary greatly in the strength of theirrestricted) TCR transgenic thymocytes, which could
agonist properties (Figures 1 and 2), yet none of themcause CD4 lineage development (or deletion at higher
induces any commitment to the CD4 lineage. One wayligand densities) in the presence of CD4, actually pro-
to explain the failure of T1, a stronger agonist than E1,moted CD8 lineage commitment in CD48 mice (Ma-
to select CD41 cells from CD88OT-1 thymocytes maytechak et al., 1996). These class II±restricted CD81 cells
be to postulate that cells that commit to the CD4 lineagewere dependent on class I in a non±allele-specific man-
following the TCR±class I interaction retain CD4 expres-ner, suggesting that the CD8 coreceptor was participat-
sion, which then inhibits continued signaling throughing in this lineage choice as well (Figure 8, arrow 4).
the TCR by sequestering Lck (Teh et al., 1991). However,One prediction of the quantitative instructive model
given the efficient and roughly equal selection of CD8is that by increasing the strength of the signal that a
lineage cells by both T1 and E1 ligands, we think it isthymocyte receives via TCR±MHC interactions, an MHC
more likely that the thymocytes are preferentially com-class I±restricted thymocyte could be selected into the
mitting to the CD8 lineage as a consequence of theCD4 lineage. Our present data together with work pub-
TCR±MHC class I interaction.lished previously using OT-1 transgenic mice make the
In conclusion, this model separates the sum of signalspoint that switching from CD8 to CD4 lineage commit-
received by developing thymocytes into the contributionment cannot occur by increasing or decreasing TCR
of the coreceptor and the strength of TCR±MHC interac-affinity for the positively selecting ligand (Figure 8,
tions. As discussed, previous reports have shown thatarrows 1 and 2). Previously, we have shown that exten-
the alteration of coreceptor contribution can redirectsive titration of agonist peptides into FTOC of the OT-1
lineage commitment, and we propose, based on ourTCR transgenic thymocytes on a b2m8 background led
data, that even in the absence of coreceptor, the TCR±from no selection, into the CD8 lineage, and then to
MHC interaction may deliver an instructive signal thatdeletion of CD8 lineage cells (Hogquist et al., 1994; Hog-
quist et al., 1995). Importantly, we cannot push cells into directs the lineage choice of developing thymocytes.
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Experimental Procedures 0.5 mCi of [3H]thymidine and harvested, and incorporated radioactiv-
ity was measured (Hogquist et al., 1995). Alternatively, after 24 hr,
BrdU (Sigma Chemical, St. Louis, MO) was added to cultures to aAnimals
OT-1 TCR transgenic mice that express a Va2, Vb5 T cell receptor final concentration of 5 mg/ml for 18 hr. BrdU-pulsed cultures were
then prepared for flow cytometric analysis to determine the pheno-from a C57BL/6-derived CTL clone recognizing the naturally pro-
cessed peptide of ovalbumin, OVA257±264, presented by H-2Kb (Hog- type of proliferating cells.
quist et al., 1994) were bred to CD8a8 (Fung-Leung et al., 1991a),
b2-microglobulin8 (Koller et al., 1990), or C57BL/6 (Jackson Labora- Flow Cytometry and Cell Sorting
tory, Bar Harbor, ME) mice. Timed matings were set up by placing Thymocytes were stained for FACS analysis with biotinylated anti-
one male in a cage with three females for 16 hr. The day that the Va2 (B20.1.1), anti-HSA (Pharmingen, San Diego, CA), or anti-H-2Kb
male was removed was considered day 1 of gestation. (Y3) (American Type Culture Collection, Rockville, MD) followed by
FITC-conjugated anti-CD8, PE-conjugated anti-CD4 (Pharmingen,
Peptides San Diego, CA), and Tri-color±conjugated streptavidin (Caltag Labo-
Octameric, H-2Kb binding peptides (OVA257±264 [SIINFEKL]; posi- ratories).
tion 1 variants E1 [EIINFEKL] andT1 [TIINFEKL]; VOVA [RGYNYEKL]; Cells from BrdU-pulsed cultures were prepared for flow cytometry
and polySER [SSYSYSSL]) were synthesized by Research Genetics as previously described (Tough and Sprent, 1994). In brief, cells
(Huntsville, AL) or with an Applied Biosystems Synergy peptide syn- were surface stained with anti-Va2, followed by PE-conjugated anti-
thesizer (Foster City, CA). Peptides were purified by high-perfor- CD4 and Tri-color±conjugated streptavidin. Next, cells were resus-
mance liquid chromatography (Research Genetics or Shimadzu, Ky- pended in 0.5 ml of 0.15 M NaCl, and 1.2 ml of 95% ethanol was
oto, Japan) and quantitated by a BCA assay (Pierce, Rockford, IL). added dropwise while mixing followed by 30 min of incubation.
All peptides used were determined to bind H-2Kb with similar affinity Cells were washed with phosphate-buffered saline (PBS) and then
using the RMA-S stabilization assay (Schumacher et al., 1990). incubated in 1% paraformaldehyde with 0.01% Tween 20 for 30 min
at room temperature followed by 30 min on ice. Cells were washed
again in PBS and then incubated for 10 min with 50 Kunitz units/mlIn Vitro Thymocyte Deletion Assay
of DNAse I (Sigma Chemical) in 0.15 M NaCl, 4.2 mM MgCl2, andThymocytes from CD88OT-1 mice or nonselecting OT-1 (b2m8OT-1)
10 mM HCl. Cells were centrifuged and supernatants removed, andmice were harvested, and 5 3 105 thymocytes and 104 irradiated
10 ml of FITC-conjugated anti-BrdU (Becton Dickinson, Mountain(30,000 rad) EL4 cells were aliquotted into 96-well round-bottom
View, CA) was added for 30 min and followed by a wash with PBS.microtiter plates in RP10 media (RPMI 1640 [GIBCO-BRL, Life Tech-
Samples were analyzed on a FACScan (Becton Dickinson) and ana-nologies, Grand Island, NY] with 10% fetal bovine serum, penicillin,
lyzed using Reproman Software (True Facts Software, Seattle, WA).streptomycin, L-glutamine, and 2-mercaptoethanol). Peptides were
For all samples, dead cells were excluded based on forward andadded to indicated final concentrations. Cultures were incubated
side scatter.at 378C, 5% CO2 for 18 hr. Following culture, thymocytes were
For sorting of pure populations of thymocytes from FTOC, cellsstained for three-color flow cytometric analysis with biotin-conju-
were harvested and stained for CD8, CD4, and Va2 as describedgated CD69 followed by fluorescein isothiocyanate (FITC)±con-
above. Samples were sorted using a FACStarPLUS (Becton Dickinson,jugated anti-CD8, phycoerythrin (PE)±conjugated anti-CD4(Phar-
Mt. View, CA). Sorted populations were contaminated with less thanmingen, San Diego, CA), and Tri-color±conjugated streptavidin
0.3% of the other sorted population.(Caltag Laboratories, South San Francisco, CA). Thirty thousand
events were collected for each sample. To calculate percentage
deletion, the number of viable cells falling into a CD4hi gate for CD88 Detection of HPRT, CD4, and CD8b mRNA by RT-PCR
thymocytes or CD4hiCD8hi gate for CD8WT thymocytes was used in Total RNAwas isolated from sorted populations of thymocytes using
the following formula: percentage deletion 5 100 2 (100 3 [per- RNA-STAT-60 (TEL-TEST ªB,º Friendswood, TX) with yeast tRNA
centage viable CD4hi(CD8hi) cells with peptide/percentage viable as a carrier.RNA was reverse transcribed using oligo (dT)12±18 primers
CD4hi(CD8hi) cells without peptide]) (Barnden et al., 1994). Mean and SUPERSCRIPT II reverse transcriptase (GIBCO-BRL, Life Tech-
fluorescence intensity of CD69 staining for total ungated cells was nologies). The levels of PCR product for HPRT (hypoxanthine phos-
used to compare CD69 induction. phoribosyltransferase), a housekeeping gene, were used to normal-
ize input amounts of template for all reactions. Three-fold dilutions
CTL Lysis Assay of approximately equivalent amounts of cDNA were used as tem-
A CTL line was established from RAG8OT-1 mice. EL4 cells were plate in PCR with primers specific for HPRT, CD4, or CD8b. The
labeled with [51Cr]sodium chromate for 1 hr at 378C. Targets were number of cycles of amplification for each primer set was deter-
washed three times, and 104 cells were placed in wells of a 96-well mined to yield product in the linear range. Primers used to detect
round-bottom plate. 104 CTL effectors were added to each well. HPRT were specific for exons 7/8 59-GATACAGGCCAGACTTTG
Test peptides wereadded at various concentrations. Anti-CD8 (2.43) TTG-39 and exon 9 59-GGTAGGCTGGCCTATAGGCT-39. Primers
ascites was added at a 1:200 dilution for the duration of the assay used to detect CD4 were specific for exon 4 59-GATCGTTTCCTCTC
where indicated. Plates were incubated at 378C for 4 hr. Supernatant ATCATC-39 and exon 6 59-CAGGGCTGGAAGAAAGAATC-39. Prim-
from each well was counted, and the percentage specific lysis was ers used to detect CD8b were specific for exon 2 59-CTCTCTGGA
calculated. GCAGCTCTGCCC-39 and exon 3 59-GGTTGGGGCAGTTGTAGGA
AGG-39. Half of the product from each PCR reaction was electro-
phoresed on a 1.75% agarose gel, which was then stained withFetal Thymic Organ Culture
ethidium bromide.Thymic lobes were harvested from mice on day 16 of gestation as
previously described (Hogquist et al., 1993). Lobes were placed
Received February 21, 1997.on cellulose ester filters (Millipore, Bedford, MA) that were set on
Gelfoam sponges (Upjohn, Kalamazoo, MI) in RP10 media without
or with peptide at 50 mM. Lobes were incubated in a humidity cham- Acknowledgments
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